Zobrazeno 1 - 10
of 27
pro vyhledávání: '"David D. Schaffer"'
Publikováno v:
Toxicology and Applied Pharmacology. 104:543-547
The ability of five antagonists to prevent the central nervous system's depressant effects of amitraz in dogs was evaluated using a shuttle avoidance paradigm. All drugs were injected iv into six male dogs trained to avoid a 1-mA shock by jumping ove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc6fde275ac4f7be5e03fab0af0b4327
https://doi.org/10.1016/0041-008x(90)90176-u
https://doi.org/10.1016/0041-008x(90)90176-u
Autor:
David D Schaffer
Publikováno v:
Comparative Biochemistry and Physiology Part A: Physiology. 72:371-375
1. 1. Neural correlates of electrically evoked mating calling in the isolated frog brainstem, when quantitated, showed striking similarities to patterns of calling in intact anurans. 2. 2. Alterations in the quantitated patterns of neural correlates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::688fd764b2aa7e4aebce8de969cc72f2
https://doi.org/10.1016/0300-9629(82)90233-x
https://doi.org/10.1016/0300-9629(82)90233-x
Autor:
Dale A. Schoeller, George H Lambert, Alfred L. Baker, David D Schaffer, Hana Josephs, Alvin N. Kotake
Publikováno v:
Clinical Pharmacology and Therapeutics. 32:261-269
The optimal conditions for performing the caffeine CO2 breath test (CBT) were investigated in smokers and nonsmokers. Caffeine labeled with13C or 14C in all three (1, 3, and 7) methyl groups or specifically in the 1-, 3-, or 7-methyl groups were oral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9960e24208961b1a3c02c9cb2a7c5bb7
https://doi.org/10.1038/clpt.1982.157
https://doi.org/10.1038/clpt.1982.157
Publikováno v:
Life sciences. 39(11)
Recent investigations have suggested that the alpha 2-adrenoreceptor agonist B-HT 920 is also a dopamine (DA) agonist with a selectivity for presynaptic receptors. In the present study, the emetic effect of B-HT 920 was investigated. Intravenous inje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::963f7733deea10799f10864a4c8b210b
https://pubmed.ncbi.nlm.nih.gov/2875373
https://pubmed.ncbi.nlm.nih.gov/2875373
Publikováno v:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). 184(3)
Recent evidence suggests that catecholamines inhibit insulin release by stimulating alpha 2-adrenoreceptors in beta-cells of the pancreatic islets. In the present study, iv injections of 0.1 and 0.3 mg/kg of yohimbine, an alpha 2-adrenoreceptor antag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a84790215c646ea2281d22966c046b4
https://pubmed.ncbi.nlm.nih.gov/3547411
https://pubmed.ncbi.nlm.nih.gov/3547411
Autor:
Calton MA; 4D Molecular Therapeutics, Emeryville, California, United States., Croze RH; 4D Molecular Therapeutics, Emeryville, California, United States., Burns C; 4D Molecular Therapeutics, Emeryville, California, United States., Beliakoff G; 4D Molecular Therapeutics, Emeryville, California, United States., Vazin T; 4D Molecular Therapeutics, Emeryville, California, United States., Szymanski P; 4D Molecular Therapeutics, Emeryville, California, United States., Schmitt C; 4D Molecular Therapeutics, Emeryville, California, United States., Klein A; 4D Molecular Therapeutics, Emeryville, California, United States., Leong M; 4D Molecular Therapeutics, Emeryville, California, United States., Quezada M; 4D Molecular Therapeutics, Emeryville, California, United States., Holt J; 4D Molecular Therapeutics, Emeryville, California, United States., Bolender G; 4D Molecular Therapeutics, Emeryville, California, United States., Barglow K; 4D Molecular Therapeutics, Emeryville, California, United States., Khoday D; 4D Molecular Therapeutics, Emeryville, California, United States., Mason T; 4D Molecular Therapeutics, Emeryville, California, United States., Delaria K; 4D Molecular Therapeutics, Emeryville, California, United States., Hassanipour M; 4D Molecular Therapeutics, Emeryville, California, United States., Kotterman M; 4D Molecular Therapeutics, Emeryville, California, United States., Khanani AM; Sierra Eye Associates, Reno, Nevada, United States.; University of Nevada, Reno School of Medicine, Reno, Nevada, United States., Schaffer D; University of California, Berkeley, California, United States., Francis P; 4D Molecular Therapeutics, Emeryville, California, United States., Kirn D; 4D Molecular Therapeutics, Emeryville, California, United States.; University of California, Berkeley, California, United States.
Publikováno v:
Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2024 Dec 02; Vol. 65 (14), pp. 1.
Publikováno v:
International ophthalmology clinics [Int Ophthalmol Clin] 2021 Jul 01; Vol. 61 (3), pp. 59-89.
Autor:
Chiu JS; Department of Pediatrics, Massachusetts General Hospital, Boston, MA, USA. jchiu@mgh.harvard.edu.; Division of Cardiology, Department of Pediatrics, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, USA. jchiu@mgh.harvard.edu., Lahoud-Rahme M; Department of Pediatrics, Massachusetts General Hospital, Boston, MA, USA.; Division of Cardiology, Department of Pediatrics, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, USA., Schaffer D; Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA., Cohen A; Department of Pediatrics, Massachusetts General Hospital, Boston, MA, USA.; Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA., Samuels-Kalow M; Department of Pediatrics, Massachusetts General Hospital, Boston, MA, USA.; Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA.
Publikováno v:
Pediatric cardiology [Pediatr Cardiol] 2020 Oct; Vol. 41 (7), pp. 1526-1528. Date of Electronic Publication: 2020 Jun 15.
Autor:
Barnes C; Department of Chemical and Biomolecular Engineering, University of California, Berkeley, CA, USA., Scheideler O; Department of Bioengineering, University of California, Berkeley, CA, USA; The UC Berkeley-UCSF Graduate Program in Bioengineering, University of California, Berkeley, CA 94720, USA., Schaffer D; Department of Chemical and Biomolecular Engineering, University of California, Berkeley, CA, USA; Department of Bioengineering, University of California, Berkeley, CA, USA; The Helen Wills Neuroscience Institute, University of California, Berkeley, CA, USA; Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA. Electronic address: schaffer@berkeley.edu.
Publikováno v:
Current opinion in biotechnology [Curr Opin Biotechnol] 2019 Dec; Vol. 60, pp. 99-103. Date of Electronic Publication: 2019 Feb 23.
Autor:
Schaffer D, Shvartsman SY
Publikováno v:
Current opinion in biotechnology [Curr Opin Biotechnol] 2018 Aug; Vol. 52, pp. iv-v.